ProCE Banner Activity

Multidisciplinary Approach to Evaluation and Treatment of Tardive Dyskinesia

Podcast Episodes

Greg Mattingly, MD, and W. Clay Jackson, MD, DipTh, discuss a multidisciplinary approach to the evaluation and treatment of patients with tardive dyskinesia.

Released: November 16, 2021

Expiration: November 15, 2022

No longer available for credit.

Share

Faculty

Greg W. Mattingly

Greg W. Mattingly, MD

Greg W. Mattingly, MD

Associate Clinical Professor

Department of Psychiatry

Washington University School of Medicine

President

St. Charles Psychiatry Associates

St. Louis, Missouri

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant provided by

Neurocrine Biosciences

Faculty Disclosure

Primary Author

Greg W. Mattingly, MD

Greg W. Mattingly, MD

Associate Clinical Professor

Department of Psychiatry

Washington University School of Medicine

President

St. Charles Psychiatry Associates

St. Louis, Missouri

Greg Mattingly, MD, has disclosed that he has received consulting fees from AbbVie, Acadia, Alkermes, Axsome, Eisai, Ironshore, Intracellular, Janssen, Lundbeck, Neos, Neurocrine, Otsuka, Redax, Roche, Rhodes, Sage, Shire, Sunovion, Supernus, Takeda, Teva, and Trispharma; funds for research support from AbbVie, Acadia, Alkermes, Avanir, Axsome, Boehringer Ingelheim, Emalex, Janssen, Medgenics, NLS-1 Pharma AG, Redax, Roche, Sage, Shire, Sunovion, Supernus, Takeda, and Teva; and fees for non-CME/CE services from AbbVie, Alkermes, Eisai, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Supernus, Takeda, and Trispharma.